These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15682630)

  • 1. Employee knowledge of a managed pharmacy benefit in a large corporation.
    Miller MJ; Desselle SP
    Manag Care Interface; 2005 Jan; 18(1):33-42. PubMed ID: 15682630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumer responses to a pharmacy benefit report card.
    Nair KV; Valuck RJ
    J Health Care Finance; 2004; 31(1):55-72. PubMed ID: 15816229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing an effective generic prescription drug program.
    Jones JD
    Benefits Q; 2003; 19(1):14-8. PubMed ID: 12608114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing pharmacy benefits cost-effectively for an aging workforce.
    Miller W; Bertucio C
    Empl Benefits J; 2002 Sep; 27(3):37-40. PubMed ID: 12219562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
    Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
    Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between older adults' knowledge of their drug coverage and medication cost problems.
    Piette JD; Heisler M
    J Am Geriatr Soc; 2006 Jan; 54(1):91-6. PubMed ID: 16420203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of a hierarchical Bayes method for utility estimation in a choice-based conjoint analysis of prescription benefit plans including medication therapy management services.
    Wellman GS; Vidican C
    Res Social Adm Pharm; 2008 Sep; 4(3):218-30. PubMed ID: 18794033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
    Sullivan PW; Nair KV; Patel BV
    Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the lack of employee knowledge of pharmacy benefits.
    Giaquinta D
    Manag Care Interface; 2005 Jan; 18(1):25-6. PubMed ID: 15682629
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits for employees with children with ADHD: findings from the Collaborative Employee Benefit Study.
    Perrin JM; Fluet C; Kuhlthau KA; Anderson B; Wells N; Epstein S; Allen D; Tobias C
    J Dev Behav Pediatr; 2005 Feb; 26(1):3-8. PubMed ID: 15718875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription drug benefits and Canada's uninsured.
    Dewa CS; Hoch JS; Steele L
    Int J Law Psychiatry; 2005; 28(5):496-513. PubMed ID: 16125777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of premium, copayments, and health status on the choice of health plans.
    Naessens JM; Khan M; Shah ND; Wagie A; Pautz RA; Campbell CR
    Med Care; 2008 Oct; 46(10):1033-40. PubMed ID: 18815524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulary tier placement for commonly prescribed branded drugs: benchmarking and creation of a preferred placement index.
    Mullins CD; Palumbo FB; Saba M
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):377-84. PubMed ID: 17567239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between a tiered pharmacy benefit plan and medication usage, health status, and disability absence days--one employer's experience.
    Burton WN; Chen CY; Schultz AB; Edington DW
    J Occup Environ Med; 2008 Oct; 50(10):1176-84. PubMed ID: 18849763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of health-related quality of life information in managed care formulary decision-making.
    Wu WK; Sause RB; Zacker C
    Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug insurance instability and its correlates: results from the 2000 Medical Expenditure Panel Survey.
    Gupta K; Cline RR; Schondelmeyer SW
    Res Social Adm Pharm; 2006 Jun; 2(2):232-53. PubMed ID: 17138510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tough decisions that no one wants to make.
    Taylor J; Jacobs M
    Benefits Q; 2003; 19(1):19-29. PubMed ID: 12608115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy.
    Berger J
    Am J Manag Care; 2007 Apr; 13 Suppl 2():S55-8. PubMed ID: 17417934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.